MARKET

CRMD

CRMD

Cormedix
NASDAQ
6.92
+0.21
+3.13%
Opening 10:01 03/30 EDT
OPEN
6.72
PREV CLOSE
6.71
HIGH
6.98
LOW
6.68
VOLUME
114.67K
TURNOVER
--
52 WEEK HIGH
17.43
52 WEEK LOW
5.60
MARKET CAP
547.03M
P/E (TTM)
3.408
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CRMD last week (0323-0327)?
Weekly Report · 4h ago
Weekly Report: what happened at CRMD last week (0316-0320)?
Weekly Report · 03/23 09:32
Weekly Report: what happened at CRMD last week (0309-0313)?
Weekly Report · 03/16 09:31
Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead
TipRanks · 03/11 00:08
Weekly Report: what happened at CRMD last week (0302-0306)?
Weekly Report · 03/09 09:32
CorMedix Reaffirms DefenCath 2027 Sales and Outlook
TipRanks · 03/06 22:30
CorMedix affirms FY26 revenue view of $300M-$320M, consensus $308.7M
TipRanks · 03/06 22:20
CorMedix price target lowered to $13 from $15 at Leerink
TipRanks · 03/06 17:05
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.